Regulation of annexin I in rheumatoid synovial cells by glucocorticoids and interleukin-1

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Morand, Eric F ^a   Hall, Pam ^a   Hutchinson, Paul ^a   Yang, Yuan H ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOCORTIN 1; MESSENGER RNA; ANTIINFLAMMATORY AGENT;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RHEUMATOID ARTHRITIS; RNA ANALYSIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE; UPREGULATION; BIOSYNTHESIS; CYTOLOGY; FIBROBLAST; FLOW CYTOMETRY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIUM;

ANIMALIA;

ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; DEXAMETHASONE; FIBROBLASTS; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 33645571626     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/73835     Document Type: Article

References (30)

1. Laan RF, Jansen TL, van Riel PL. Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford). 1999;38(1):6-12.
2. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science (London). 1998;94(6):557-572.
3. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. The Journal of Rheumatology. 1997;24(9):1758-1764.
4. Philip JG, Flower RJ, Buckingham JC. Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuroreport. 1997;8(8):1871-1876.
5. Comera C, Russo-Marie F. Glucocorticoid-induced annexin 1 secretion by monocytes and peritoneal leukocytes. British Journal of Pharmacology. 1995;115(6):1043-1047.
6. Perretti M, Flower RJ. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. Journal of Immunology. 1993;150(3):992-999.
7. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nature Medicine. 1996;2(11):1259-1262.
8. Perretti M, Ahluwalia A, Harris JG, Harris HJ, Wheller SK, Flower RJ. Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1. British Journal of Pharmacology. 1996;117(6):1145-1154.
9. Yang YH, Leech M, Hutchinson P, Holdsworth SR, Morand EF. Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation. 1997;21(6):583-596.
10. Yang YH, Hutchinson P, Morand EF. Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis. Arthritis and Rheumatism. 1999;42(7):1538-1544.
11. Solito E, Romero IA, Marullo S, Russo-Marie F, Weksler BB. Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. Journal of Immunology. 2000;165(3):1573-1581.
12. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clinical Immunology and Immunopathology. 1995;76(2):195-202.
13. Goulding NJ, Dixey J, Morand EF, et al. Differential distribution of annexins-I, -II, -IV, and -VI in synovium. Annals of the Rheumatic Diseases. 1995;54(10):841-845.
14. Yang YH, Hutchinson P, Santos LL, Morand EF. Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1. Clinical and Experimental Immunology. 1998;111(1):117-122.
15. Yang YH, Hall P, Milenkovski G, et al. Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice. The American Journal of Pathology. 2004;164(1):109-117.
16. Yang YH, Morand EF, Getting SJ, et al. Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. Arthritis and Rheumatism. 2004;50(3):976-984.
17. Sampey AV, Hutchinson P, Morand EF. Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes. Mediators of Inflammation. 2000;9(3-4):125-132.
18. Sampey AV, Hutchinson P, Morand EF. Annexin I surface binding sites and their regulation on human fibroblast-like synoviocytes. Arthritis and Rheumatism. 2000;43(11):2537-2542.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism. 1988;31(3):315-324.
20. Leech M, Metz C, Hall P, et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis and Rheumatism. 1999;42(8):1601-1608.
21. Morand EF, Hutchinson P, Boyce NW, Goulding NJ, Holdsworth SR. Expression of intracellular lipocortin 1 in human peripheral blood leukocyte subsets. AustNZJMed. 1995;25:405.
22. Cirino G, Flower RJ. Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro. Prostaglandins. 1987;34(1):59-62.
23. Gold R, Pepinsky RB, Zettl UK, Toyka KV, Hartung HP. Lipocortin-1 (annexin-1) suppresses activation of autoimmune T cell lines in the Lewis rat. Journal of Neuroimmunology. 1996;69(1-2):157-164.
24. Kim KM, Kim DK, Park YM, Kim CK, Na DS. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Letters. 1994;343(3):251-255.
25. Barchowsky A, Frleta D, Vincenti MP. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts. Cytokine. 2000;12(10):1469-1479.
26. Browning JL, Ward MP, Wallner BP, Pepinsky RB. Studies on the structural properties of lipocortin-1 and the regulation of its synthesis by steroids. Progress in Clinical and Biological Research. 1990;349:27-45.
27. Bloom JW. Mitogen-activated protein kinase pathways: therapeutic targets in steroid resistance? The Journal of Allergy and Clinical Immunology. 2004;114(5):1055-1058.
28. Derijk RH, Schaaf MJ, Turner G, et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. The Journal of Rheumatology. 2001;28(11):2383-2388.
29. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ. Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis and Rheumatism. 1994;37(2):207-211.
30. Goulding NJ, Jefferiss CM, Pan L, Rigby WF, Guyre PM. Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis and Rheumatism. 1992;35(11):1395-1397.